TransMedics (TMDX) EBIT Margin (2018 - 2026)
TransMedics' (TMDX) quarterly EBIT Margin came in at 7.64% in Q1 2026, down 1147.0% year-on-year from 0.73% in Q1 2025, and down 42.23% quarter-over-quarter from 13.23% in Q4 2025.
TransMedics (TMDX) EBIT Margin (2018 - 2026) Analysis & Trends
TransMedics' EBIT Margin history runs 9 years deep, the most recent figure standing at 7.64% for Q1 2026.
- On a quarterly basis, EBIT Margin fell 1147.0% year-over-year to 7.64% in Q1 2026; TTM through Mar 2026 was 14.85%, a 409.0% increase from a year earlier, with the FY2025 full-year figure at 17.93%, up 944.0% from the prior year.
- EBIT Margin eased to 7.64% in Q1 2026 per TMDX's latest filing, from 13.23% in the prior quarter.
- Across five years, EBIT Margin topped out at 23.24% in Q2 2025 and bottomed at 59.0% in Q1 2022.
- The 5-year median for EBIT Margin is 3.61% (2024), against an average of 4.82%.
- Across the five-year window, EBIT Margin jumped 19676 bps in 2022 and plunged 2107 bps in 2023, its largest moves.
- Year by year, EBIT Margin stood at 21.61% in 2022, then jumped by 115 bps to 3.21% in 2023, then soared by 122 bps to 7.11% in 2024, then soared by 86 bps to 13.23% in 2025, then plunged by 42 bps to 7.64% in 2026.
- Per Business Quant, the three latest TMDX EBIT Margin figures stand at 7.64% (Q1 2026), 13.23% (Q4 2025), and 16.2% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 7.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64% |
| Dec 31, 2025 | 13.23% |
| Sep 30, 2025 | 16.20% |
| Jun 30, 2025 | 23.24% |
| Mar 31, 2025 | 19.12% |
| Dec 31, 2024 | 7.11% |
| Sep 30, 2024 | 3.61% |
| Jun 30, 2024 | 10.94% |
| Mar 31, 2024 | 12.82% |
| Dec 31, 2023 | 3.21% |
| Sep 30, 2023 | -42.65% |
| Jun 30, 2023 | -1.73% |
| Mar 31, 2023 | -5.03% |
| Dec 31, 2022 | -21.61% |
| Sep 30, 2022 | -21.59% |
| Jun 30, 2022 | -47.49% |
| Mar 31, 2022 | -59.00% |
| Dec 31, 2021 | -132.57% |
| Sep 30, 2021 | -218.34% |
| Jun 30, 2021 | -113.86% |